Lineage Cell Therapeutics
LCTX
#8827
Rank
A$0.17 B
Marketcap
$0.79
Share price
-0.62%
Change (1 day)
-50.28%
Change (1 year)

Lineage Cell Therapeutics (LCTX) Fails to deliver data

Key failure to deliver metrics for Lineage Cell Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lineage Cell Therapeutics (LCTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lineage Cell Therapeutics (LCTX) - since 2019

Volume in USD (price x number of shares), data since 2019

Lineage Cell Therapeutics (LCTX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$1.49 M-21.67%
2023A$1.9 M-54.82%
2022A$4.21 M-66.55%
2021A$12.59 M159.36%
2020A$4.85 M399.21%
2019A$0.97 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$1 MA$6 M๐Ÿ‡บ๐Ÿ‡ธ USA